Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9656
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRajmalani, Bharat Ashok-
dc.date.accessioned2021-01-28T12:16:51Z-
dc.date.available2021-01-28T12:16:51Z-
dc.date.issued2020-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9656-
dc.descriptionGuided by Dr. Jigna Shahen_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPPR00940;-
dc.subjectPPR00940en_US
dc.subjectB. Pharm Project Reporten_US
dc.subject3D QSARen_US
dc.subjectAgonistsen_US
dc.subjectSchizophreniaen_US
dc.subjectPharmacologyen_US
dc.title3D QSAR on PDE10A Agonists Use to Treat Schizophreniaen_US
dc.typeProject Reporten_US
Appears in Collections:B. Pharm Project Reports

Files in This Item:
File Description SizeFormat 
PPR00940.pdfPPR009401.72 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.